Aside from ERK/MAPK signaling pathway, PI3K/AKT signaling pathway is involved in regulation of apoptosis in CRC cells, suggesting that using an agent targeting this pathway may be an effective strategy for CRC therapy. The gene discussed is AKT1; the disease is colorectal carcinoma.